Impact of improving negative symptoms on functioning in patients with schizophrenia: a post-hoc analysis of a proof-of-concept study

被引：0
作者：
Blaettler, T. [1 ]
Edgar, C. [2 ]
Garibaldi, G. [3 ]
机构：
[1] F Hoffmann La Roche Ltd, PDND Clin Dev CNS, Basel, Switzerland
[2] Roche Prod Ltd, Welwyn Garden City, England
[3] F Hoffmann La Roche Ltd, CNS Clin Dev, Basel, Switzerland
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2012年 / 22卷
关键词：
D O I：
10.1016/S0924-977X(12)70474-1
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S310 / S310
页数：1
相关论文
共 50 条
[31]   Impact of age in critically Ill infected patients: a post-hoc analysis of the INFAUCI study [J].
Moreira, Sonia Bastos ;
Baptista, Joao Pedro ;
Goncalves-Pereira, Joao ;
Pereira, Jose Manuel ;
Ribeiro, Orquidea ;
Dias, Claudia Camila ;
Froes, Filipe ;
Paiva, Jose-Artur .
EUROPEAN GERIATRIC MEDICINE, 2021, 12 (05) :1057-1064
[32]   Impact of age in critically Ill infected patients: a post-hoc analysis of the INFAUCI study [J].
Sónia Bastos Moreira ;
João Pedro Baptista ;
João Gonçalves-Pereira ;
José Manuel Pereira ;
Orquídea Ribeiro ;
Claúdia Camila Dias ;
Filipe Froes ;
José-Artur Paiva .
European Geriatric Medicine, 2021, 12 :1057-1064
[33]   EFFECT OF BREXPIPRAZOLE ON ENGAGEMENT IN PATIENTS WITH SCHIZOPHRENIA: POST-HOC ANALYSIS OF THREE STUDIES [J].
Ismail, Zahinoor ;
Pedersen, Anne M. ;
Thase, Michael E. ;
Meehan, Stine Rasmussen ;
Weiss, Catherine ;
Larsen, Klaus Groes ;
Chen, Dalei ;
Nylander, Anna-Greta ;
Baker, Ross A. ;
McIntyre, Roger .
SCHIZOPHRENIA BULLETIN, 2020, 46 :S208-S209
[34]   Effect of bifidobacterium breve A-1 on anxiety and depressive symptoms in schizophrenia: A proof-of-concept study [J].
Okubo, Ryo ;
Koga, Minori ;
Katsumata, Noriko ;
Odamaki, Toshitaka ;
Matsuyama, Shiina ;
Oka, Matsuhiko ;
Narita, Hisashi ;
Hashimoto, Naoki ;
Kusumi, Ichiro ;
Xiao, Jinzhong ;
Matsuoka, Yutaka J. .
JOURNAL OF AFFECTIVE DISORDERS, 2019, 245 :377-385
[35]   Targeting negative symptoms in schizophrenia: Results from a proof-of-concept trial assessing prefrontal anodic tDCS protocol [J].
Kurimori, Milton ;
Shiozawa, Pedro ;
Bikson, Marom ;
Aboseria, Mohamed ;
Cordeiro, Quirino .
SCHIZOPHRENIA RESEARCH, 2015, 166 (1-3) :362-363
[36]   Cariprazine vs risperidone efficacy on predominant negative symptoms of schizophrenia: post hoc analysis of negative symptoms subdomains [J].
Laszlovszky, I. ;
Barabassy, A. ;
Szatmari, B. ;
Harsanyi, J. ;
Szalai, E. ;
Nemeth, G. .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 :S902-S903
[37]   Effect of Lurasidone on Life Engagement in Schizophrenia: Post-Hoc Analysis of the JEWEL Study [J].
Maruyama, Hidenori ;
Sano, Fumiya ;
Sakaguchi, Reiko ;
Okamoto, Keisuke ;
Miura, Itaru .
NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2024, 20 :1453-1463
[38]   Positive Symptoms Respond to Add-on Aspirin in Schizophrenia Patients with High Sera CRPLevels: A Post-hoc Analysis of an RCT [J].
Weiser, Mark .
NEUROPSYCHOPHARMACOLOGY, 2014, 39 :S5-S6
[39]   BDNF-Val66Met-Polymorphism Impact on Cortical Plasticity in Schizophrenia Patients: A Proof-of-Concept Study [J].
Strube, Wolfgang ;
Nitsche, Michael A. ;
Wobrock, Thomas ;
Bunse, Tilmann ;
Rein, Bettina ;
Herrmann, Maximiliane ;
Schmitt, Andrea ;
Nieratschker, Vanessa ;
Witt, Stephanie H. ;
Rietschel, Marcella ;
Falkai, Peter ;
Hasan, Alkomiet .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2015, 18 (04) :1-11
[40]   Impact of cognitive performance and negative symptoms on psychosocial functioning in Czech schizophrenia patients [J].
L. Kalisova ;
J. Michalec ;
F. Dechterenko ;
P. Silhan ;
M. Hyza ;
M. Chlebovcova ;
M. Brenova ;
O. Bezdicek .
Schizophrenia, 9
12345